Interactions between lipopolysaccharides and blood factors on the stimulation of equine polymorphonuclear neutrophils

Veterinary Immunology and Immunopathology

Volumn 64, Issue 4, 1998, Pages 313-322

  Benbarek, H ^a   Deby Dupont, G ^a,b   Caudron, I ^a   Grulke S ^a   Deby, C ^a   Lamy, M ^a,b   Serteyn, D ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Chemiluminescence; Endotoxin; Equine neutrophils; Reactive oxygen species

Indexed keywords

ALBUMIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN; POLYMYXIN B; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; BLOOD; CHEMOLUMINESCENCE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DOSE RESPONSE; HORSE; NEUTROPHIL; NONHUMAN;

ANIMALS; BLOOD PHYSIOLOGY; DOSE-RESPONSE RELATIONSHIP, DRUG; HORSES; LIPOPOLYSACCHARIDES; NEUTROPHIL ACTIVATION; NEUTROPHILS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS; ESCHERICHIA COLI;

EID: 0032584984     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00142-1     Document Type: Article

References (30)

1. Aida Y., Pabst M.J. Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-α Immunol. 145:1990;3017-3025.
2. Aida Y., Kusumoto K., Nakatomi K., Takada H., Pabst M.J., Maeda K. An analogue of lipid-A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma. J. Leukoc. Biol. 58:1995;675-682.
3. Benbarek H., Deby-Dupont G., Deby C., Caudron I., Mathy-Hartert M., Lamy M., Serteyn D. An experimental model based on chemiluminescence for the study of the activation of isolated equine leucocytes. Res. Vet. Sciences. 61:1996;59-64.
4. Benbarek H., Deby-Dupont G., Caudron I., Deby C., Lamy M., Serteyn D. Failure of lipopolysaccharides to directly trigger the chemiluminescence response of the isolated equine polymorphonuclear leucocytes. Vet. Res. Comm. 21:1997;477-482.
5. Berczi I., Bertok L., Bereznai T. Comparative studies on the toxicity of Escherichia coli- lipopolysaccharide endotoxin in various animal species. Can. J. Microbiol. 12:1966;1070-1071.
6. Bochsler, P.N., Slauson, D.O., Neilsen, N.R., 1992. Secretory activity of equine polymorphonuclear leukocytes: Stimulus specificity and priming effects of bacterial lipopolysaccharide, Vet. Immunol. Immunopathol. 31, pp. 241-253.
7. Briheim G., Stendahl O., Dahlgren C. Intra-and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leucocytes. Infect. Immun. 45:1984;1-5.
8. Burrows G.E. Dose-response of ponies to parenteral Escherichia coli endotoxin. Can. J. Comp. Med. 45:1981;207-210.
9. David S.A., Balaram P., Mathan V.I. Characterization of the interaction of lipid-A and lipopolysaccharide with human serum albumin: Implications for an endotoxin carrier function for albumin. J. Endotox. Res. 2:1995;99-106.
10. Dorn C.R., Coffman J.R., Schmidt D.A., Garner H.E., Addison J.B., McCune E.L. Neutropenia and salmonellosis in hospitalized horses. J. Am. Vet. Med. Assoc. 166:1975;65-67.
11. Forehand J.R., Pabst M.J., Phillips W.A., Johnston R.B. Jr. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium. J. Clin. Invest. 83:1989;74-83.
12. Fujishima S., Aikawa N. Neutrophil-mediated tissue injury and its modulation. Int. Care Med. 21:1995;277-285.
13. Henricks P.A.J., van der Tol M.E., Thyssen R.M., van Asbeck B.S., Verhoef J. Escherichia coli-lipopolysaccharides diminish and enhance cell function of polymorphonuclear leukocytes. Infect. Immun. 15:1983;294-301.
14. Hunt R.J., Allen D., Moore J.N. Effect of the endotoxin on equine digital hemodynamics and starling forces. Am. J. Vet. Res. 19:1987;25-28.
15. Meyers K., Reed S., Keck M., Clem M., Baily W. Circulating endotoxin-like substance(s) and altered hemostasis in horse with gastrointestinal disorders: An interim report. Am. J. Vet. Res. 43:1982;2233-2238.
16. Moore R.A., Bates N.C., Hancock R.E. Interaction of polycationic antibiotics with Pseudomonas aeruginosa-lipopolysaccharide and lipid-A studied by using dansyl-polymyxin. Antimicrob. Agents Chemother. 29:1986;496-500.
17. Nicotra J., Orsini A.J., Debari V.A. Chemiluminescence response of the human polymorphonuclear neutrophil to lipopolysaccharides. Cell. Biophys. 7:1985;283-291.
18. Proctor R.A. Endotoxin in vitro interactions with human neutrophils: Depression of chemiluminescence, oxygen consumption, superoxide production, and killing. Infect. Immun. 25:1979;912-921.
19. Pycock J.F., Allen E., Morris T.H. Rapid, single-step isolation of equine neutrophils on a discontinuous Percoll density gradient. Res. Vet. Sciences. 42:1987;411-412.
20. Sample A.K., Czuprynski C.J. Priming and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha. J. Leukoc. Biol. 49:1991;107-115.
21. Sample A.K., Czuprynski C.J. Bovine neutrophils chemiluminescence is preferentially stimulated by homologous IL-1, but inhibited by the human IL-1 receptor antagonist. Vet. Immunol. Immunopathol. 41:1994;165-172.
22. Seethanathan P., Bottoms G.D., Schafer K. Characterization of release of tumor necrosis factor, interleukin-1, and superoxide anion from equine white blood cells in response to endotoxin. Am. J. Vet. Res. 51:1990;1221-1225.
23. Shapira L., Champagne C., Gordon B., Amar S., Van Dyke T.E. Lipopolysaccharide priming of superoxide release by human neutrophils: Role of membrane CD14 and serum LPS binding protein. Inflammation. 19:1995;289-295.
24. Tool A.T.J., Pabst M.J., Roos D., Verhoeven A.J. Phosphatidyl-inositol-linked CD14 is involved in priming of human neutrophils by lipopolysaccharide (LPS), but not in the inactivation of LPS. Prog. Clin. Biol. Res. 388:1994;137-145.
25. Vosbeck K., Tobias P., Mueller H., Allen R.A., Arfors K.E., Ulevitch R.J., Sklar L.A. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J. Leukoc. Biol. 47:1990;97-104.
26. Ward D.S., Fessler J.F., Bottoms G.D., Turek J. Equine endotoxemia: Cardiovascular, eicosanoid, hematologic, blood chemical, and plasma enzyme alterations. Am. J. Vet. Res. 48:1987;1150-1156.
27. Webster, R.O., Hong, S.R., Johnstan, R.B. Jr., Henson, P.M., 1980. Biological effects of the human complement fragments C5a and C5b desarg on neutrophil function. Immunopharmacology 2, 201-219.
28. Wilson M.E., Jones D.P., Munkenbeck P., Morrison D.C. Serum-dependent and independent effects of bacterial lipopolysaccharides on human neutrophil oxidative capacity in vitro. J. Reticuloendothel. Soc. 31:1982;43-57.
29. Wright S.D., Ramos R.A., Patel M., Miller D.S. Septin: A factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J. Exp. Med. 176:1992;719-727.
30. 2 release and chemiluminescence. J. Cell. Physiol. 146:1991;164-269.